| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Biao He | |
| David M Jablons | |||
| Liang You | |||
| Zhidong Xu | |||
| Yu-Ching Lin | |||
| Jae Kim | |||
| Josephine Chou | |||
| P2860 | cites work | Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas | Q80544879 |
| Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma | Q80551012 | ||
| Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma | Q80559739 | ||
| [Expression and significance of PTEN in nasopharyngeal carcinoma] | Q81409600 | ||
| Expression of p53 protein and primary tumour volume in patients with nasopharyngeal carcinoma | Q81807931 | ||
| [Cross-talk between c-Jun/Ets1 involved in EB virus-encoded latent membrane protein 1 regulates expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma] | Q81836777 | ||
| Prognostic value of Survivin and Livin in nasopharyngeal carcinoma | Q82567403 | ||
| [Significance of EGFR and p-ERK expression in nasopharyngeal carcinoma] | Q83884933 | ||
| [The relationship between hypermethylation of the PTEN promoter and laryngeal squamous cell carcinoma] | Q83890595 | ||
| p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities | Q22003973 | ||
| Control of apoptosis and mitotic spindle checkpoint by survivin | Q22008570 | ||
| Chfr defines a mitotic stress checkpoint that delays entry into metaphase | Q22254761 | ||
| The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 | ||
| ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways | Q24321528 | ||
| A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma | Q24322614 | ||
| Cyclooxygenase regulates angiogenesis induced by colon cancer cells | Q24336248 | ||
| Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells | Q24554359 | ||
| Epigenetic inactivation of CHFR in human tumors | Q24670147 | ||
| Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5 | Q24675583 | ||
| E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex | Q24685706 | ||
| Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
| The retinoblastoma protein and cell cycle control | Q27860722 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| The DNA damage response: putting checkpoints in perspective | Q28131713 | ||
| Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma | Q38451930 | ||
| Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy | Q38455460 | ||
| Oral mucosal tumor inhibition by ibuprofen. | Q38522173 | ||
| Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups | Q38896500 | ||
| Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis | Q39444400 | ||
| A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. | Q39736828 | ||
| Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells | Q39795545 | ||
| Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases | Q40117040 | ||
| Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells | Q40131916 | ||
| Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth | Q40138689 | ||
| Wnt inhibitory factor inhibits lung cancer cell growth | Q40167186 | ||
| Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling | Q40192981 | ||
| Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells | Q40209246 | ||
| Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 | ||
| HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis | Q34570497 | ||
| Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma | Q34570584 | ||
| Nasopharyngeal cancer in Greenland. The incidence in an Arctic Eskimo population | Q34618090 | ||
| Telomerase inhibition and the future management of head-and-neck cancer | Q34688638 | ||
| The effect of migration on the risk of nasopharyngeal cancer among Chinese. | Q34700342 | ||
| LMP1 strain variants: biological and molecular properties. | Q34717145 | ||
| Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects | Q34722621 | ||
| Increased MAPK expression and activity in primary human hepatocellular carcinoma | Q34741778 | ||
| An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking | Q35000168 | ||
| Genetic and epigenetic changes in nasopharyngeal carcinoma. | Q35008876 | ||
| Matrix metalloproteinases in tumor-host cell communication | Q35030681 | ||
| Identification of CDK4 as a target of c-MYC. | Q35051802 | ||
| Epstein-Barr virus-recent advances | Q35076846 | ||
| The p53 network in head and neck cancer | Q35078417 | ||
| Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. | Q35122385 | ||
| Regulators of G1 cyclin-dependent kinases and cancers | Q35186469 | ||
| Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications | Q35588568 | ||
| Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma. | Q36032530 | ||
| Wnt signaling in lung cancer | Q36101348 | ||
| Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. | Q36167487 | ||
| Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells | Q36242117 | ||
| Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma | Q36611031 | ||
| Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts | Q36696963 | ||
| Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. | Q36810617 | ||
| Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer | Q37376029 | ||
| Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia | Q37429299 | ||
| Accumulation of cytoplasmic beta-catenin and nuclear glycogen synthase kinase 3beta in Epstein-Barr virus-infected cells | Q37583544 | ||
| Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway. | Q37595549 | ||
| Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients | Q38052106 | ||
| Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma | Q38273731 | ||
| Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway | Q38309301 | ||
| Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer | Q38435843 | ||
| Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma | Q38445188 | ||
| Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas | Q28202829 | ||
| Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity | Q28209840 | ||
| The Fos family of transcription factors and their role in tumourigenesis | Q28275076 | ||
| Cell cycle targets of Ras/Raf signalling | Q28285940 | ||
| IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs | Q28291174 | ||
| Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis | Q28344462 | ||
| Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A | Q28618873 | ||
| NF-kappaB in cancer: from innocent bystander to major culprit | Q29614603 | ||
| Regulation of transcription by MAP kinase cascades | Q29618477 | ||
| Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death | Q29620000 | ||
| Cancer Incidence in Five Continents. Comparability and quality of data | Q30809860 | ||
| Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays. | Q31105358 | ||
| The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma | Q32045194 | ||
| Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation revealed by serial analysis of gene expression | Q32120327 | ||
| Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9 | Q33265945 | ||
| MYC oncogenes and human neoplastic disease | Q33667340 | ||
| Role of p27 in prostate carcinogenesis | Q33715175 | ||
| Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling | Q33781678 | ||
| New insights into the control of MAP kinase pathways | Q33783573 | ||
| Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. | Q33815241 | ||
| Matrix metalloproteases in head and neck cancer | Q33863220 | ||
| Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner | Q33962291 | ||
| Matrix metalloproteinases in tumor invasion and metastasis | Q34136635 | ||
| Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer | Q34222573 | ||
| Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis | Q34228703 | ||
| Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex | Q34287597 | ||
| BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways | Q34320007 | ||
| Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells | Q34351473 | ||
| Translocations involving c-myc and c-myc function | Q34405431 | ||
| The activation of Akt/PKB signaling pathway and cell survival. | Q34405519 | ||
| The absence of NF-kappaB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis | Q34442990 | ||
| Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines | Q34486671 | ||
| Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression | Q34494021 | ||
| Cloning and characterization of the BRD7 gene promoter | Q34540911 | ||
| Elucidation of the c-Jun N-terminal kinase pathway mediated by Estein-Barr virus-encoded latent membrane protein 1. | Q34551310 | ||
| CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma | Q40247402 | ||
| Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase | Q40281326 | ||
| Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells | Q40293195 | ||
| The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer | Q40299123 | ||
| Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression | Q40310448 | ||
| Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines. | Q40358529 | ||
| Host cyclooxygenase-2 modulates carcinoma growth. | Q40365112 | ||
| Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. | Q40399583 | ||
| Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma. | Q40402154 | ||
| Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation | Q40413167 | ||
| Latent membrane protein 1 encoded by Epstein-Barr virus modulates directly and synchronously cyclin D1 and p16 by newly forming a c-Jun/Jun B heterodimer in nasopharyngeal carcinoma cell line | Q40413322 | ||
| Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression. | Q40455834 | ||
| Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1. | Q40470698 | ||
| Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells. | Q40481455 | ||
| MDM2 expression in EBV-infected nasopharyngeal carcinoma cells | Q40510932 | ||
| Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1. | Q40538392 | ||
| Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells | Q40547103 | ||
| Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line | Q40558959 | ||
| RECK is a target of Epstein–Barr virus latent membrane protein 1 | Q40616852 | ||
| Alterations of Biologic Properties and Gene Expression in Nasopharyngeal Epithelial Cells by the Epstein-Barr Virus–Encoded Latent Membrane Protein 1 | Q40647912 | ||
| Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy | Q40734444 | ||
| Involvement of wild-type p53 in radiation-induced c-Jun N-terminal kinase activation in human thyroid cells. | Q40766371 | ||
| Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma | Q40860124 | ||
| A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells | Q40912553 | ||
| Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells | Q40993570 | ||
| Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). | Q41044165 | ||
| Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus | Q41436239 | ||
| Changing views of the role of matrix metalloproteinases in metastasis | Q41592276 | ||
| Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role | Q41674960 | ||
| Deregulated cyclin E induces chromosome instability | Q41692394 | ||
| Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product. | Q42130716 | ||
| High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? | Q42491304 | ||
| Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. | Q42500751 | ||
| Transient activation of c-Jun NH2-terminal kinase by growth factors influences survival but not apoptosis of human thyrocytes | Q42508079 | ||
| Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis | Q43482949 | ||
| IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. | Q43643486 | ||
| Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma | Q43860639 | ||
| Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma | Q45249203 | ||
| Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. | Q45286100 | ||
| Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells | Q45444546 | ||
| Prognostic role of Ebstein-Barr virus latent membrane protein-1 and interleukin-10 expression in patients with nasopharyngeal carcinoma | Q45546964 | ||
| Epstein-Barr virus latent membrane 2A (LMP2A) down-regulates telomerase reverse transcriptase (hTERT) in epithelial cell lines | Q45584265 | ||
| Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma | Q45605928 | ||
| Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. | Q45729612 | ||
| Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck | Q45736565 | ||
| Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma | Q45740001 | ||
| Absence of nuclear p16 from Epstein-Barr virus-associated undifferentiated nasopharyngeal carcinomas | Q45744905 | ||
| Role of enhanced radiosensitivity and the tumor-specific suicide gene vector in gene therapy of nasopharyngeal carcinoma | Q45867639 | ||
| Nasopharyngeal carcinoma in Chinese—Salted fish or inhaled smoke? | Q46439618 | ||
| Effects of basic fibroblast growth factor on protein kinase B activity and c-fos expression in CNE- I nasopharyngeal carcinoma cell line | Q46441826 | ||
| Phosphatidylinositol 3-kinase regulates early differentiation in human laryngeal keratinocytes | Q46608353 | ||
| Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro | Q46613450 | ||
| Clinicopathologic significance of plasma matrix metalloproteinase-2 and -9 levels in patients with undifferentiated nasopharyngeal carcinoma | Q47625748 | ||
| Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. | Q47820459 | ||
| BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways | Q48079928 | ||
| Detection of c-myc gene expression in nasopharyngeal carcinoma by nonradioactive in situ hybridization and immunohistochemistry. | Q50887618 | ||
| Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. | Q51584737 | ||
| Lack of correlation between G1 arrest and radiation age-response in three synchronized human tumour cell lines. | Q52132973 | ||
| Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. | Q52827239 | ||
| The association between CD99 and LMP-1 expression in nasopharyngeal carcinoma. | Q53347439 | ||
| Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. | Q53390564 | ||
| Expression of p16, nm23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinoma. | Q53395585 | ||
| Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array. | Q53407139 | ||
| Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. | Q53431175 | ||
| Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. | Q53435962 | ||
| Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma | Q53461208 | ||
| An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. | Q53541156 | ||
| 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers | Q55480673 | ||
| Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer | Q57424487 | ||
| The Detection of thec-mycandrasOncogenes in Nasopharyngeal Carcinoma by Immunohistochemistry | Q58068928 | ||
| Ras-independent Activation of the Raf/MEK/ERK Pathway upon Calcium-induced Differentiation of Keratinocytes | Q58181035 | ||
| Nasopharyngeal carcinoma | Q59344163 | ||
| Detection of subclinical riasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy | Q59344294 | ||
| Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes | Q63407040 | ||
| Epidermal growth factor receptor expression in human lung cancer cell lines | Q69818833 | ||
| Squamous cell carcinoma of the nasopharynx. An analysis of failure patterns after radiation therapy | Q70099274 | ||
| Growth factors and cancer | Q70121988 | ||
| Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 | Q70787131 | ||
| High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma | Q71254205 | ||
| Down regulation of bcl-2 by p53 in nasopharyngeal carcinoma and lack of detection of its specific t(14;18) chromosomal translocation in fixed tissues | Q71327889 | ||
| ras mutations are uncommon in nasopharyngeal carcinoma | Q71362577 | ||
| Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents | Q71739769 | ||
| The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation | Q71833616 | ||
| Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck | Q72571234 | ||
| Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications | Q73006549 | ||
| Thyroid cancer | Q73412063 | ||
| Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3 | Q73540287 | ||
| Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1 | Q73673875 | ||
| Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma | Q73696172 | ||
| Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas | Q73705764 | ||
| Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 | Q74463750 | ||
| Cell cycle control and cancer | Q74678692 | ||
| Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma | Q77217463 | ||
| [Expression of telomerase subunits and its relationship with telomerase activity in nasopharyngeal carcinoma] | Q77541277 | ||
| Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination | Q77556339 | ||
| Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis | Q77643702 | ||
| The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells | Q77904111 | ||
| Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation | Q77995454 | ||
| Low expression levels of p27 correlate with loco-regional recurrence in nasopharyngeal carcinoma | Q78685119 | ||
| Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features | Q80539313 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 946-963 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Head & Neck | Q13703062 |
| P1476 | title | Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis | |
| P478 | volume | 30 |
| Q35885173 | A Genome Wide Study of Copy Number Variation Associated with Nasopharyngeal Carcinoma in Malaysian Chinese Identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci |
| Q52618019 | A Review of Promising Natural Chemopreventive Agents for Head and Neck Cancer. |
| Q37793789 | A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene |
| Q34022398 | A functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population. |
| Q28943422 | A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci |
| Q37327734 | A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation |
| Q38867865 | A role of MMP-14 in the regulation of invasiveness of nasopharyngeal carcinoma |
| Q89220563 | ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma |
| Q34105105 | Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma |
| Q92646331 | Activation of c-Jun/JNK signaling predicts poor prognosis in nasopharyngeal carcinoma |
| Q39391675 | Adenovirus-mediated RNA interference targeting FOXM1 transcription factor suppresses cell proliferation and tumor growth of nasopharyngeal carcinoma |
| Q93002617 | An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma |
| Q21202158 | An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma |
| Q54537376 | Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysis. |
| Q39310631 | Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species |
| Q89273955 | Association of E-cadherin methylation with risk of nasopharyngeal cancer: A meta-analysis |
| Q37659154 | BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma |
| Q39828896 | Bax inhibitor-1 mediates apoptosis-resistance in human nasopharyngeal carcinoma cells |
| Q28087059 | Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma |
| Q37397986 | Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study |
| Q39155509 | Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma. |
| Q37728618 | Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling |
| Q54979044 | Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt/β-catenin-Lin28/let7-PDK1 cascade. |
| Q91975248 | Clinical Implications of Plasma Epstein-Barr Virus DNA in Children and Adolescent Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy |
| Q35125619 | Combinatorial gene targeting hTERT and BI-1 in CNE-2 nasopharyngeal carcinoma cell line |
| Q36729524 | Common variations in TERT-CLPTM1L locus are reproducibly associated with the risk of nasopharyngeal carcinoma in Chinese populations |
| Q41891609 | Curcumin treatment alters ERK-1/2 signaling in vitro and inhibits nasopharyngeal carcinoma proliferation in mouse xenografts |
| Q60053966 | Cyclooxygenase-2 Expression and Its Correlation with Primary Tumor Size and Lymph Node Involvement in Nasopharyngeal Carcinoma |
| Q37106316 | Delivery system for DNAzymes using arginine-modified hydroxyapatite nanoparticles for therapeutic application in a nasopharyngeal carcinoma model |
| Q38493022 | Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells |
| Q48167801 | Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy |
| Q42287399 | Distinct functional regions of the human polymeric immunoglobulin receptor |
| Q37618118 | Does honey have the characteristics of natural cancer vaccine? |
| Q39504497 | Downregulation of p57kip² promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells |
| Q55001674 | Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma. |
| Q34353826 | Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo |
| Q35176423 | Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation |
| Q33887581 | Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. |
| Q90481228 | Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans |
| Q37350214 | Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells |
| Q54256444 | Epstein-Barr virus stably confers an invasive phenotype to epithelial cells through reprogramming of the WNT pathway. |
| Q58185285 | Expression of MASPIN and angiogenin in nasopharyngeal carcinoma: Novel preliminary clinico-pathological evidence |
| Q34566972 | Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients |
| Q45370913 | FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation |
| Q36164237 | FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway. |
| Q37716550 | FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition |
| Q47279097 | Factors associated with early diagnosis in pediatric vs adult nasopharyngeal carcinoma |
| Q45191513 | Fascin1 expression predicts poor prognosis in patients with nasopharyngeal carcinoma and correlates with tumor invasion |
| Q37340443 | Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers |
| Q28268527 | Forkhead box C1 induces epithelial‑mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma |
| Q33870813 | Functional PIN1 promoter polymorphisms associated with risk of nasopharyngeal carcinoma in Southern Chinese populations |
| Q38802471 | Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis |
| Q34730405 | Functional expression of chloride channels and their roles in the cell cycle and cell proliferation in highly differentiated nasopharyngeal carcinoma cells |
| Q41436597 | Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients |
| Q46264870 | Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia |
| Q26851109 | Histogenetic concepts, terminology and categorization of biphasic tumours of the oral and maxillofacial region |
| Q36065177 | Honey and cancer: sustainable inverse relationship particularly for developing nations-a review. |
| Q92167887 | Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis |
| Q45384656 | Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis |
| Q82352444 | Identification of candidate molecular markers of nasopharyngeal carcinoma by tissue microarray and in situ hybridization |
| Q36872700 | Identifying novel genes and chemicals related to nasopharyngeal cancer in a heterogeneous network |
| Q42560665 | Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer. |
| Q37569650 | Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma |
| Q34371614 | Increased expression of IRS-1 is associated with lymph node metastasis in nasopharyngeal carcinoma. |
| Q39159102 | Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness |
| Q33889850 | Increased expression of flotillin-2 protein as a novel biomarker for lymph node metastasis in nasopharyngeal carcinoma |
| Q90354167 | Increased expression of heat shock protein (HSP) 10 and HSP70 correlates with poor prognosis of nasopharyngeal carcinoma |
| Q39680485 | Indole-3-carbinol (I3C)-induced apoptosis in nasopharyngeal cancer cells through Fas/FasL and MAPK pathway |
| Q34849728 | Inhibition of GSK 3β activity is associated with excessive EZH2 expression and enhanced tumour invasion in nasopharyngeal carcinoma |
| Q38446740 | Integrated pathway analysis of nasopharyngeal carcinoma implicates the axonemal dynein complex in the Malaysian cohort |
| Q36544611 | Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma. |
| Q38633665 | JNK pathway inhibition enhances chemotherapeutic sensitivity to Adriamycin in nasopharyngeal carcinoma cells |
| Q28540586 | Large scale analysis of phenotype-pathway relationships based on GWAS results |
| Q40452568 | Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value. |
| Q34320473 | Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival |
| Q36782557 | Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways |
| Q83396650 | Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis |
| Q93386603 | Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer |
| Q47877936 | MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells |
| Q40171125 | MYC and hsa‑miRNA‑423‑5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA‑mRNA‑pathway network integrated analysis |
| Q58759078 | Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth |
| Q33654173 | Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression |
| Q34708005 | MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma |
| Q38751308 | MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway |
| Q38841730 | MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells |
| Q52599797 | MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma. |
| Q34247536 | MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma |
| Q42723195 | MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma |
| Q92839486 | MicroRNA-140 inhibits tumor progression in nasopharyngeal carcinoma by targeting CXCR4 |
| Q38755853 | MicroRNA-15a Inhibits Proliferation and Induces Apoptosis in CNE1 Nasopharyngeal Carcinoma Cells |
| Q38811364 | MicroRNA-200c plays an oncogenic role in nasopharyngeal carcinoma by targeting PTEN. |
| Q37402828 | Molecular Detection of Epstein - Barr virus in Nasopharyngeal Carcinoma among Sudanese population |
| Q35072994 | Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma |
| Q38385856 | Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079). |
| Q33598631 | NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation |
| Q92726867 | NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition |
| Q37257200 | NOLC1, an enhancer of nasopharyngeal carcinoma progression, is essential for TP53 to regulate MDM2 expression |
| Q52628569 | Nasopharyngeal Carcinoma Protein Interaction Mapping Analysis via Proteomic Approaches |
| Q47950153 | Nasopharyngeal Carcinoma: A 15 Year Study with Respect to Clinicodemography and Survival Analysis |
| Q37198074 | Nasopharyngeal cancer in Sudan: epidemiology, clinical and histological characteristics |
| Q42096715 | Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers. |
| Q36262238 | Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9 |
| Q38922626 | Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2. |
| Q55286123 | Non-canonical WNT6/WNT10A signal factor expression in EBV+ post-transplant smooth muscle tumors. |
| Q38656647 | Nutlin-3, A P53-Mdm2 Antagonist For Nasopharyngeal Carcinoma Treatment |
| Q90333146 | Over-expression of cyclo-oxygenase-2 predicts poor survival of patients with nasopharyngeal carcinoma: a meta-analysis |
| Q33864140 | Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma |
| Q44416846 | Overexpression of CDC28 protein kinase regulatory subunit 1B confers an independent prognostic factor in nasopharyngeal carcinoma |
| Q35097767 | Phosphorylated Mnk1 and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma |
| Q89456397 | Polymorphisms of CYP2E1 rs2031920 is not Associated with Risk of Nasopharyngeal Carcinoma in Minangkabau Ethnic Group |
| Q44833814 | Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. |
| Q47155578 | Prognostic Value of Molecular Markers and Implication for Molecular Targeted Therapies in Nasopharyngeal Carcinoma: An Update in an Era of New Targeted Molecules Development |
| Q38133425 | Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis |
| Q45751366 | Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma. |
| Q84066530 | Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma |
| Q38600570 | Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma: a systematic review and meta-analysis |
| Q64228155 | Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma |
| Q38903947 | Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma |
| Q33594982 | Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma |
| Q42560502 | Quercetin-induced inhibition and synergistic activity with cisplatin - a chemotherapeutic strategy for nasopharyngeal carcinoma cells |
| Q59125738 | RGS17 inhibits tumorigenesis and improves 5-fluorouracil sensitivity in nasopharyngeal carcinoma |
| Q41173985 | Real-time In vivo Diagnosis of Nasopharyngeal Carcinoma Using Rapid Fiber-Optic Raman Spectroscopy |
| Q39665370 | Resveratrol-induced p53-independent apoptosis of human nasopharyngeal carcinoma cells is correlated with the downregulation of ΔNp63 |
| Q35080861 | Retracted: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis |
| Q34286259 | Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population |
| Q96576801 | S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1 |
| Q35975562 | Salivary Anionic Changes after Radiotherapy for Nasopharyngeal Carcinoma: A 1-Year Prospective Study |
| Q38931451 | ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma |
| Q37260036 | Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC. |
| Q37697046 | Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma. |
| Q36327912 | Targeting Jab1/CSN5 in nasopharyngeal carcinoma |
| Q39025516 | Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress |
| Q61447791 | Taxol-Resistant Gene 1 (Txr1) Mediates Oxaliplatin Resistance by Inducing Autophagy in Human Nasopharyngeal Carcinoma Cells |
| Q35851682 | The cadherin-catenin complex in laryngeal squamous cell carcinoma. |
| Q35145996 | The cadherin-catenin complex in nasopharyngeal carcinoma |
| Q39521568 | The expression of cyclin G in nasopharyngeal carcinoma and its significance |
| Q64946489 | The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs. |
| Q92218667 | Tissue P16 is Associated with Smoking Status among Indonesian Nasopharyngeal Carcinoma Subjects |
| Q38631755 | Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1. |
| Q24299572 | Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties |
| Q35974869 | Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma |
| Q39095740 | Using computational strategies to predict potential drugs for nasopharyngeal carcinoma |
| Q43205422 | WNT pathway in laryngeal squamous cell carcinoma and nasopharyngeal carcinoma. |
| Q36418335 | Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma |
| Q39612057 | Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63. |
| Q37085002 | YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway |
| Q38701014 | lncRNA C22orf32-1 contributes to the tumorigenesis of nasopharyngeal carcinoma |
| Q42237944 | miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4. |
| Q33756203 | miR-18a downregulates DICER1 and promotes proliferation and metastasis of nasopharyngeal carcinoma |
| Q34299316 | miR-200a Regulates Epithelial-Mesenchymal to Stem-like Transition via ZEB2 and β-Catenin Signaling |
| Q36716288 | miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22 |
| Q38796204 | β-Catenin is important for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma |
Search more.